Business | Press Trust of India | Friday April 22, 2016
Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.
www.ndtv.com/business